| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |